120 related articles for article (PubMed ID: 2880663)
1. Comparison of the immediate effects of two beta-blocking drugs: a nonselective and a cardioselective with modest ISA in exercise-induced angina.
Berkenboom GM; Ibrahim T; Abramowicz M; Degre SG
Cardiology; 1987; 74(1):43-8. PubMed ID: 2880663
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.
Rydén L
J Intern Med; 1992 Jan; 231(1):7-11. PubMed ID: 1346268
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
Subramanian VB; Bowles MJ; Davies AB; Raftery EB
Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
[TBL] [Abstract][Full Text] [Related]
4. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
[TBL] [Abstract][Full Text] [Related]
5. Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.
Dahlöf B; Danielson M; Andersson O; Thulin T; Ohman P; Mörlin C; Boberg J; Karlberg BE; Jern S; Hansson L
Br J Clin Pharmacol; 1984 Dec; 18(6):831-6. PubMed ID: 6152175
[TBL] [Abstract][Full Text] [Related]
6. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
Klein W; Fluch N; Brandt D
Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of esmolol for unstable angina pectoris.
Wallis DE; Pope C; Littman WJ; Scanlon PJ
Am J Cardiol; 1988 Nov; 62(16):1033-7. PubMed ID: 2903659
[TBL] [Abstract][Full Text] [Related]
8. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
Boberg J; Larsen FF; Pehrsson SK
Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
[TBL] [Abstract][Full Text] [Related]
9. A new water-soluble, selective beta-blocker with intrinsic sympathomimetic activity (ICI 141.292) in angina pectoris.
Erikssen J; Rollag A; Otterstad JE
Acta Med Scand; 1988; 223(1):35-43. PubMed ID: 2894747
[TBL] [Abstract][Full Text] [Related]
10. Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.
Kostis JB; Frishman W; Hosler MH; Thorsen NL; Gonasun L; Weinstein J
Am Heart J; 1982 Aug; 104(2 Pt 2):496-504. PubMed ID: 7102536
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of intrinsic sympathomimetic activity of beta blockers.
Kostis JB; DeFelice EA; Frishman W; Hosler M; Krieger SK; Aglitz N; Kuo PT
Angiology; 1981 Nov; 32(11):780-7. PubMed ID: 6119937
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
Harry JD
Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of diltiazem, propranolol, and placebo on exercise performance using radionuclide ventriculography in patients with symptomatic coronary artery disease: results of a double-blind, randomized, crossover study.
Anderson JL; Wagner JM; Datz FL; Christian PE; Bray BE; Taylor AT
Am Heart J; 1984 Apr; 107(4):698-706. PubMed ID: 6367406
[TBL] [Abstract][Full Text] [Related]
14. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
Borer JS; Comerford MB; Sowton E
J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
Hansteen V; Endresen K; Hellemann H; Eriksen II; Brorssen O; Ekeli T; Day M; Baber NS
Br J Clin Pharmacol; 1984 May; 17(5):579-84. PubMed ID: 6203546
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of beta-blockers with and without intrinsic sympathomimetic activity on hemodynamics and left ventricular function at rest and during exercise in patients with coronary artery disease.
Choong CY; Roubin GS; Harris PJ; Tokuyasu Y; Shen WF; Bautovich GJ; Kelly DT
J Cardiovasc Pharmacol; 1986; 8(3):441-8. PubMed ID: 2425156
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of once daily penbutolol in chronic stable angina. An objective comparison with long-acting propranolol.
Bowles MJ; Khurmi NS; Bala Subramanian V; Raftery EB
Int J Cardiol; 1984 Feb; 5(2):131-42. PubMed ID: 6365803
[TBL] [Abstract][Full Text] [Related]
18. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
Prida XE; Feldman RL; Hill JA; Pepine CJ
Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of bevantolol for chronic, stable angina pectoris.
Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
Am J Cardiol; 1986 Nov; 58(12):28E-34E. PubMed ID: 2878598
[TBL] [Abstract][Full Text] [Related]
20. Nadolol compared to propranolol for treating chronic stable angina pectoris.
Miller LA; Crawford MH; O'Rourke RA
Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
